<i>son</i> reduction decreases T cell numbers. by Rebecca L. Belmonte (8384103)

Data from all independent trials of adhesion assay (in Fig 5B–5C) and CP activity assay (in Fig 5D–5F). by Han Jiang (195350)

<i>ism1</i> knockdown decreases erythrocytes. by Arturo Berrun (5216003)

Proteome analysis of plasma from ATTR individuals. by Gonçalo da Costa (198731)

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…Cell stiffness was measured before and after the nanorobotic surgery and decreases from 30.0±1.5 kPa to 20.5±2.8 kPa, respectively. …”

Activated caspase-3 decreases following CO exposure. by Ying Cheng (288456)

Bortezomib decreases osteoclasts and improves fracture repair in mice. by Hengwei Zhang (2397610)

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

Correlates of osteogenic differentiation. by Fabian Westhauser (5314436)

Interferon-β release is strongly decreased after MNV-S99 infection. by Sandra Niendorf (2832785)

Modifying pregnenolone to decrease its lipophilicity results in decreased cellular uptake. by Jeffrey M. McManus (7512926)

CHW consultation rates for children under 5 years decrease with increasing CHW geographic dispersion and increase with increasing distance to the nearest PHC. by Michelle V. Evans (3967046)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

“…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”

A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…(B) The mutation was confirmed by Sanger sequencing of PCR amplicons from <i>Mrps34</i>^{<i>mut/mut</i>} and littermate matched <i>Mrps34</i>^<i>wt/wt</i> mice. (C) Mutation in the nuclear gene encoding the mitochondrial MRPS34 protein leads to its decreased abundance. …”

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

SCS DKO parasites have decreased mitochondrial ATP content, but are capable of ATP import and ATP hydrolysis. by Gergana Taleva (17131885)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

“…Graph represents relative fold-induction of 5S rRNA levels in comparison to mock-treated cells, with normalisation to cell number. …”